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Prognostic Value of Coronary Magnetic Resonance
Angiography for Prediction of Cardiac Events in
Patients With Suspected Coronary Artery Disease
Yeonyee E. Yoon, MD,*† Kakuya Kitagawa, MD,* Shingo Kato, MD,* Masaki Ishida, MD,*
Hiroshi Nakajima, MD,‡ Tairo Kurita, MD,§ Masaaki Ito, MD,‡ Hajime Sakuma, MD*
Mie, Japan
Objectives This study sought to determine whether whole-heart coronary magnetic resonance angiography (CMRA) can pre-
dict cardiac events in patients with suspected coronary artery disease.
Background Recent studies demonstrated that the presence of stenosis on coronary computed tomography angiography has
a significant prognostic impact on the prediction of cardiac events. However, the prognostic value of whole-heart
CMRA is unknown.
Methods We studied 207 patients with suspected coronary artery disease who underwent non-contrast-enhanced free-
breathing whole-heart CMRA acquired with a 1.5-T MR system and 32-channel cardiac coils. The presence of
significant coronary stenosis (50% diameter reduction) was visually determined on sliding thin- maximum in-
tensity projection images. Follow-up information was obtained for occurrence of severe cardiac events (cardiac
death, myocardial infarction, and unstable angina) and all cardiac events (additionally including revasculariza-
tion90 days after CMRA).
Results During a median follow-up of 25 months, 10 cardiac events, of which 5 were severe, were observed in 84 pa-
tients with significant stenosis. Whereas, in 123 patients without significant stenosis, only 1 cardiac event with
no severe event was observed. Kaplan-Meier curves demonstrated a significant difference in event-free survival
between the 2 groups for severe events (annual event rate, 3.9% and 0%, respectively; log-rank test, p  0.003),
as well as for all cardiac events (6.3% and 0.3%; p  0.001). Cox regression analysis showed that presence of
significant stenosis on CMRA was associated with a 20-fold hazard increase for all cardiac events (hazard ra-
tio: 20.78; 95% confidence interval: 2.65 to 162.70; p  0.001).
Conclusions Whole-heart CMRA is useful for predicting the future risk for cardiac events in patients with suspected coronary artery
disease. (J Am Coll Cardiol 2012;60:2316–22) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.07.060Coronary artery disease (CAD) remains the leading cause of
morbidity and mortality in developed countries (1). The
availability of effective treatment options by both medical
and interventional therapy makes it important to identify
patients at risk, and it is equally important to identify
patients who do not need treatment. Although conventional
coronary X-ray angiography is the current gold standard for
the detection of CAD, it is expensive, potentially harmful,
and associated with a small risk of serious complications.
From the *Department of Radiology, Mie University Hospital, Tsu, Mie, Japan;
†Division of Cardiology, Cardiovascular Center, Seoul National University
Bundang Hospital, Seongnam, Republic of Korea; ‡Department of Cardiology, Mie
University Hospital, Tsu, Mie, Japan; and the §Department of Cardiology, Matsusaka
Central Hospital, Matsusaka, Mie, Japan. The authors have reported that they have no
relationships relevant to the contents of this paper to disclose.Manuscript received February 3, 2012; revised manuscript received June 14, 2012,
accepted July 3, 2012.Coronary computed tomography (CT) angiography offers
noninvasive approach for evaluation of coronary arteries and
showed high diagnostic accuracy to detect and exclude
obstructive CAD (2–4). In addition, recent studies demon-
strated that the presence of stenosis on coronary CT
angiography is associated with increased adverse cardiac
events in patients with suspected CAD (5–8). However,
coronary CT angiography has limitations in terms of use of
iodinated contrast agent and radiation exposure.
See page 2323
Coronary magnetic resonance angiography (CMRA) has
emerged as a possible noninvasive alternative for visualizing
coronary arteries (9). Recently, 3-dimensional (3D) steady-
state free precession (SSFP) whole-heart CMRA, which
allows visualization of all major coronary arteries with a
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December 4, 2012:2316–22 Prognostic Value of CMRAsingle axial 3D acquisition, has become the method of
choice for MR coronary imaging (10–13). Because of an
intrinsically high blood signal intensity (14), SSFP whole-
heart CMRA images can be acquired without administering
contrast medium. Several studies evaluated the diagnostic
performance of 1.5-T SSFP whole-heart CMRA for de-
tecting significant coronary artery stenosis on invasive cor-
onary angiography (15–18). However, to date, data on the
prognostic value of whole-heart CMRA are not available.
Therefore, in this study, we investigated whether CMRA
can predict cardiac events in patients with suspected CAD.
Methods
Study population. The medical records were reviewed in
278 consecutive adult patients with suspected CAD who
underwent non-contrast-enhanced free-breathing whole-heart
CMRA between January 1, 2007 and December 31, 2008.
The acquisition and analysis of CMRA was approved by the
Institutional Review Board and written informed consent was
obtained from all subjects at the time of CMRA. Of the 278
patients who had CMRA, 52 patients with known prior CAD
at the time of CMRA, including prior myocardial infarction,
CAD on prior catheterization, or prior revascularization were
excluded. Thus, the presence of significant stenosis on CMRA
was assessed and the clinical information was obtained in the
remaining 226 patients with suspected CAD but without
previously known CAD. The Institutional Review Board had
approved this retrospective study to determine the prognostic
value of CMRA and waived the need for additional written
informed consent.
Image acquisition. MR images were obtained by using a
1.5-T MR imaging unit (Achieva, Philips Medical Systems,
Best, the Netherlands) with 32-channel cardiac coils.
Isosorbide dinitrate (5 mg) was administered sublingually to
all subjects before CMRA acquisition. Beta-blockers were
not used in this study. Initial survey images were obtained to
determine the position of the heart and diaphragm. Then,
reference images were acquired to evaluate the individual
coil sensitivities for parallel imaging acquisition while the
patient breathed freely. To monitor motion of the right
coronary artery, transaxial cine MR images were acquired
using SSFP sequence while breathing freely (repetition
time: 2.6 ms, echo time: 1.3 ms, flip angle: 60°, field of view:
320  320  120 mm, acquisition matrix: 128  128,
ardiac phases: 50, sensitivity encoding factor: 3.0, imaging
ime: 3 s). A patient-specific acquisition window was set
uring either systole or diastole, depending on the phase of
inimal motion of the right coronary artery (13,15). Free-
reathing, navigator-gated whole-heart CMRA was ob-
ained using a 3D, segmented SFFP sequence with radial
-space sampling (repetition time: 4.6 ms, echo time: 2.3
s, flip angle: 90°, full Fourier encoding, excitations per
ardiac cycle: 20 to 50, navigator gating window: 2.5 mm,
eld of view: 280  280  120 mm, acquisition matrices:
56  256  80, reconstruction matrices: 512  512  l60). Myocardial and venous
lood signal were suppressed us-
ng T2 preparation. Spectral pre-
aturation with inversion recov-
ry was also applied to suppress
picardial fat signals.
mage analysis. CMRA images
ere transferred to a 3D image
erver (Aquarius NET server,
era-Recon, Inc., San Mateo,
alifornia). The coronary artery
ree was segmented according to
he modified American College
f Cardiology/American Heart
ssociation classification (19).
Two observers, blinded to clin-
cal information, evaluated the entire coronary arteries on
hole-heart CMRA by using sliding thin-slab maximum
ntensity projection to determine the presence or absence of
ignificant luminal narrowing (50% diameter reduction)
15,18,20). Disagreement between the 2 observers was settled
y a consensus reading. All coronary arteries were included for
he evaluation regardless of the image quality of CMRA, by
sing an intention-to-read approach.
ollow-up. Follow-up information was obtained by either
linical visits or telephone interviews. All reported events were
erified by hospital records or direct contacts with the attend-
ng physicians. The following clinical events were recorded: 1)
ardiac death; 2) nonfatal myocardial infarction; 3) unstable
ngina pectoris requiring hospitalization; and 4) coronary
evascularization (by either bypass surgery or percutaneous
oronary intervention). Cardiac death was defined as death
aused by acute myocardial infarction, ventricular arrhythmias,
r refractory heart failure. In addition, information on noncar-
iac deaths was also collected. Coronary revascularizations
ccurring early after CMRA were usually performed as a result
f CMRA because patients with significant coronary artery
tenosis were recommended to have invasive angiography and
ntervention as needed (7,21). Therefore, coronary revascular-
zation procedures performed within 90 days after CMRA
ere reported separately as an outcome of clinical interest and
ere excluded from cardiac events. For follow-up analysis, all
atients undergoing early revascularization were censored at
he time of the intervention and were therefore excluded from
urther analysis.
tatistical analysis. Continuous variables are expressed as
ean SD and compared using Student t test. Age was the
nly continuous variable and was normally distributed.
ategorical variables are expressed as proportions and com-
ared by the chi-square test or Fisher exact test, as appro-
riate. A 2-sided p value of 0.05 was considered statisti-
ally significant. Kaplan-Meier curves were used to estimate
he distribution of time to cardiac events according to the
resence or absence of significant stenosis. Differences
etween time-to-event curves were compared with the
Abbreviations
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3D  3-dimensional
CAD  coronary artery
disease
CI  confidence interval(s)
CT  computed
tomography
CMRA  coronary
magnetic resonance
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HR  hazard ratio(s)
SSFP  steady-state free
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Prognostic Value of CMRA December 4, 2012:2316–22the 3-year Kaplan-Meier event rates by 3. The effect of the
significant stenosis diagnosed by CMRA on all cardiac
events was determined using the Cox regression analysis.
Results are reported as hazard ratios (HR) with 95%
confidence intervals (CI). All analyses were performed with
the SPSS statistical package (version 19.0, SPSS, Inc.,
Chicago, Illinois).
Results
Of the 226 patients, 19 (8.4%) patients who were lost to
follow-up were excluded. Thus, 207 patients (128 men;
mean age: 68  10 years) were available for the final
nalysis. All 3 major coronary arteries were visualized in all
tudy subjects. The number of segments that were visible
nd evaluated in this study, using a modified American
Figure 1 Images in a 81-Year-Old Male Patient With Multiple R
(A) Thin-slab maximum intensity projection image and (B) conventional angiogram
in the proximal portion of the left anterior descending artery.
Figure 2 Images in a 84-Year-Old Male Patient With Chest Pain
(A) Thin-slab maximum intensity projection image and (B) conventional angiogram shoollege of Cardiology/American Heart Association classi-
cation (19), was described in Online Table 1. The most
ommon indication for CMRA was chest pain (101 [49%]),
nd other indications included dyspnea (14 [7%]), palpita-
ion (18 [9%]), and syncope (6 [3%]) (Figs. 1 and 2).
symptomatic patients (68 [33%]) mainly consisted of
hose with multiple risk factors. The detailed patient char-
cteristics and indication for CMRA are shown in Table 1.
hole-heart CMRA revealed at least 1 significant coronary
rtery stenosis in 84 of 207 studied patients (41%). Of the
4 patients with significant stenosis, 47 patients had signif-
cant CAD in only 1 coronary artery, 25 in 2 arteries, and 12
ad significant 3-vessel disease. Patients with significant
tenosis on CMRA were older and more likely to be men
Table 1).
actors
significant stenosis (red arrow)
Effort
ificant stenosis (red arrow) in the proximal portion of the left circumflex artery.isk F
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December 4, 2012:2316–22 Prognostic Value of CMRAThe median follow-up period was 25 months (interquar-
tile range 16 to 33 months). The cardiac events during
follow-up were summarized in Table 2. A total of 5 severe
cardiac events (cardiac death: n 1; unstable angina: n 4)
were observed in patients with significant stenosis, whereas
none of the patients without significant stenosis on CMRA
experienced any severe cardiac events (log-rank p  0.003).
nnualized rate of severe cardiac events was 3.9% and 0%
or patients with and without significant stenosis, respec-
ively. Kaplan-Meier curves, stratified by the presence of
ignificant stenosis for severe cardiac events are illustrated in
igure 3A. Noncardiac death occurred in 1 patient without
ignificant stenosis (malignancy: n  1) and in 2 patients
ith significant stenosis (cerebrovascular event: n  1;
rauma: n  1) (p  0.232). Those with noncardiac death
ere censored at the time of death.
Patient CharacteristicsTable 1 Patient Characteristics
All Patients
(n  207)
Clinical
Age, yrs 68 10
Male 128 (62)
Hypertension 151 (73)
Diabetes 75 (36)
Hypercholesterolemia 115 (56)
Current smoking 56 (27)
Family history of CAD 21 (10)
BMI 25 kg/m2 53 (26)
Indication for study
Chest pain 101 (49)
Dyspnea 14 (7)
Palpitation 18 (9)
Syncope 6 (3)
Asymptomatic 68 (33)
Multiple risk factors 35 (17)
Equivocal/abnormal stress test 3 (1)
Pre-operative examination 22 (11)
LV dysfunction 8 (4)
Values are mean  SD or n (%).
BMI  body mass index; CAD  coronary artery disease; LV  left
Follow-Up Events and Combined EndpointsTable 2 Follow-Up Events and Combined Endpoints
Absence of
Significant
Stenosis
(n  123)
Presence of
Significant
Stenosis
(n  84)
Log-Rank
p Value
Cardiac events
Cardiac death 0 1 (1.2%) 0.223
Nonfatal myocardial infarction 0 0 —
Unstable angina 0 4 (4.8%) 0.007
Late revascularization 1 (0.8%) 7 (8.3%) 0.001
Combined endpoint
Severe cardiac events 0 5 (6.0%) 0.003
All cardiac events 1 (0.8%) 10 (11.9%) 0.001
Noncardiac death 1 (0.8%) 2 (2.4%) 0.232pValues are n (%).A total of 25 patients with significant stenosis (25 of 84
29.8%]) underwent revascularization (percutaneous coro-
ary intervention: n  19, bypass surgery: n  6) within 90
ays after CMRA. In contrast, no one without significant
tenosis underwent early revascularization within 90 days
fter CMRA. All patients undergoing early revasculariza-
ion were censored at the time of intervention for the
urvival analysis. During follow-up, 8 patients underwent
ate (90 days after CMRA) revascularization (percutane-
us coronary intervention: n  7, bypass surgery: n  1).
ignificantly more late coronary revascularization proce-
ures were performed in patients with significant stenosis
han in those without significant stenosis (7 vs. 1 revascu-
arization procedure in patients with significant stenosis vs.
o significant stenosis, respectively; p  0.001). All cardiac
vents, including cardiac death, myocardial infarction, un-
table angina, and late revascularization were observed in 10
f 84 (11.9%) patients with significant stenosis and only in
of 123 (0.8%) patients without significant stenosis, corre-
ponding to the annual event rate of 6.3% and 0.3%.
aplan-Meier curves showed worse event-free survival in
atients with significant stenosis than in those without
ignificant stenosis (p  0.001) (Fig. 3B).
Univariate analyses of clinical variables and the presence
f significant stenosis for composite endpoints of all cardiac
vents are summarized in Table 3. As no severe cardiac
vent was observed in patients without significant stenosis,
ox regression analysis was available only for all cardiac
vents. Although current smoking (unadjusted HR: 4.88,
5% CI: 1.43 to 16.67; p  0.011) and family history of
nificant Stenosis
(n  123)
Significant Stenosis
(n  84) p Value
66 11 71 9 0.001
68 (55) 60 (71) 0.019
86 (70) 65 (77) 0.313
43 (35) 32 (38) 0.676
63 (51) 52 (62) 0.145
28 (23) 28 (33) 0.100
10 (8) 11 (13) 0.303
29 (24) 24 (29) 0.419
61 (50) 40 (48) 0.777
9 (7) 5 (6) 0.699
13 (11) 5 (6) 0.247
3 (2) 3 (4) 0.688
37 (30) 31 (37) 0.306
20 (16) 15 (18) 0.764
1 (1) 2 (2) 0.567
11 (9) 11 (13) 0.340
5 (4) 3 (4) 1.000
e.No Sigremature CAD (unadjusted HR: 3.95; 95% CI: 1.04 to
2320 Yoon et al. JACC Vol. 60, No. 22, 2012
Prognostic Value of CMRA December 4, 2012:2316–2214.99; p  0.044) were significant predictors of all cardiac
events, the presence of significant stenosis was the strongest
predictor of all cardiac events (unadjusted HR: 20.78, 95%
CI: 2.46 to 145.40; p  0.004). When adjusted to current
smoking and family history of premature CAD, presence of
significant stenosis maintained a 17-fold adjusted hazard
increase for all cardiac events (adjusted HR: 17.97, 95% CI:
2.28 to 141.74; p  0.006).
Discussion
The present study demonstrated the following findings: 1)
the frequencies of severe cardiac events as well as all cardiac
events were significantly higher in patients with significant
stenosis on CMRA in comparison with patients without
significant stenosis; 2) the absence of significant stenosis on
Figure 3 Kaplan-Meier Event-Free Survival Curves
Curves for (A) severe cardiac events and (B) all cardiac events.
Univariate Analysis of FactorsAssoci d With All Cardiac EventsTable 3 Univariate An ly is of FactorsAssociated With All Cardiac Events
All Cardiac Events
HR (95% CI) p Value
Age, yrs 1.05 (0.98–1.12) 0.189
Male 3.12 (0.67–14.47) 0.145
Hypertension 0.64 (0.19–2.19) 0.478
Diabetes 0.66 (0.18–2.50) 0.544
Hypercholesterolemia 2.08 (0.55–7.83) 0.281
Current smoking 4.88 (1.43–16.67) 0.011
Family history of CAD 3.95 (1.04–14.99) 0.044
BMI 25 kg/m2 0.99 (0.26–3.72) 0.983
Presence of significant stenosis 20.78 (2.65–162.70) 0.004
1-vessel disease (as compared with
no significant stenosis)
18.80 (2.19–161.37) 0.007
2- or 3-vessel disease (as compared with
no significant stenosis)
23.22 (2.71–199.28) 0.004CI  confidence interval(s); HR  hazard ratio(s); other abbreviations as in Table 1.CMRA can identify a population with a very low risk for
severe cardiac events (0%) and all cardiac events (0.3%)
during a median follow-up period of 25 months.
At present, coronary CT angiography appears to be the
most robust technique for noninvasive visualization of the
coronary arteries. Sixty-four–slice multidetector CT has
been shown to be a sensitive and specific tool for the
detection of significant coronary stenosis and has been
validated against conventional coronary angiography (2–4).
Although use of CMRA for assessing CAD is currently
limited due to lower spatial resolution (1 to 1.5 mm) and
lengthy imaging time (typically 5 to 15 min) and complexity
of examination that can lead to inconsistent image quality
(15,18,20), CMRA has several advantages over coronary
CT angiography (22). First, CMRA does not expose the
patients to ionizing radiation. Second, no contrast material
injection is required to obtain 1.5-T SSFP CMRA. Third,
the lumen of the coronary artery can be visualized in
patients with heavy coronary artery calcification. The diag-
nostic accuracy of whole-heart CMRA has been investi-
gated in several single-center studies, with a sensitivity of
78% to 96% and a specificity of 68% to 96% in the detection
of coronary arteries with a luminal narrowing of at least 50%
identified at conventional angiography (15–17). In a multi-
center trial by Kato et al. (18), 1.5-T whole-heart CMRA
acquired with 5-channel cardiac coils showed a high nega-
tive predictive value of 88%, indicating that CMRA is useful
for ruling out CAD in patients with suspected CAD and
thus is of value for eliminating unnecessary X-ray angiog-
raphy. In addition, 1.5-T whole-heart CMRA reliably ruled
out left main disease or 3-vessel disease with a high negative
predictive value of 99%. Although prolonged imaging time has
been a major disadvantage of whole-heart CMRA, introduc-
tion of 32-channel cardiac coils substantially reduced imaging
2321JACC Vol. 60, No. 22, 2012 Yoon et al.
December 4, 2012:2316–22 Prognostic Value of CMRAtime of CMRA, with the vessel-based sensitivity of 86% and
specificity of 93% (20).
An understanding of the prognostic value as well as the
diagnostic accuracy of the new imaging technique is impor-
tant before adopting it into clinical practice. During the last
few years, several studies reported prognostic value of
coronary CT angiography (5–7,23,24). In a study by Had-
amitzky et al. (7), the frequencies of severe and all cardiac
events were significantly higher in patients with significant
coronary stenosis on coronary CT angiography (event rate
in the first year: 1.7% and 4.3%, respectively) in comparison
with patients without significant stenosis (0.1% and 0.3%,
respectively). To our knowledge, the current study is the
first to evaluate the prognostic value of whole-heart CMRA.
Patients with significant stenosis by CMRA suffer signifi-
cantly more frequently from severe and all cardiac events
(annual event rate: 3.9% and 6.3%, respectively) than do
patients without significant stenosis (0% and 0.3%, respec-
tively). Furthermore, the high hazard ratio of 20.78 ob-
served in this study indicated that the presence of significant
stenosis on whole-heart CMRA is strongly associated with
future major cardiac events in patients with suspected CAD.
Some studies showed that many acute myocardial infarc-
tions are caused by lesions classified as nonobstructive in
previous angiograms (25,26). However, the current whole-
heart CMRA approach does not provide sufficient spatial
resolution to stratify the lesions into mild, moderate, and
severe stenosis. Methods that allow for more quantitative
analysis of luminal narrowing need to be established in the
future studies. Nevertheless, in the current study, the
presence of lumen narrowing by the visual assessment of
CMRA is proven useful for the prediction of severe cardiac
events including cardiac death, acute myocardial infarction,
and unstable angina.
It is of great clinical importance that the absence of
significant stenosis on CMRA can safely rule out the future
risk for cardiac events in symptomatic individuals. Recent
studies consistently showed annual death or myocardial
infarction rates 0.5% in patients without significant CAD
on coronary CT angiography (5–8). In the present study,
we found that the absence of significant stenosis on CMRA
was also associated with excellent prognosis with an annu-
alized rate of 0.3% for all cardiac events. This finding is of
major clinical relevance, because these patients may indeed
be safely reassured without the need for further testing.
Study limitations. Our single-center study is limited by
the relatively small number of patients affecting the preci-
sion and statistical power of our analysis and therefore needs
to be confirmed in a larger patient population. A small
number of adverse cardiac events preclude a valid multivar-
iate analysis for comparison of CMRA with other risk
predictors. In addition, the present study was performed in
patients with intermediate CAD prevalence of 41%. The
findings in this study may not be directly extrapolated to the
population with a lower prevalence of CAD. Further studies
are required to examine the prognostic value of CMRA inasymptomatic individuals. Finally, this study was performed
as a retrospective study. The diagnostic and therapeutic
procedures were not guided by a specific study protocol and
might be influenced by a result of CMRA. However, such
effects are inevitable in a study observing clinical treatment
pathways. And, in the present study, the difference in the
event rates was not influenced by complications of revascu-
larization, because patients were censored for the endpoint
of all cardiac events after the first revascularization.
Conclusions
Our current study demonstrates the capacity of CMRA for
the prediction of cardiac events in patients with suspected
CAD. The high hazard ratio observed in this study indi-
cated that the presence of significant stenosis on whole-
heart CMRA is strongly associated with future major
cardiac events in patients with suspected CAD. In addition,
the absence of significant stenosis on whole-heart CMRA is
associated with a very low risk of cardiac events. Whole-
heart CMRA permits the risk stratification of patients with
suspected CAD without exposing the subjects to radiation
or administrating contrast medium.
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Department of Radiology, Mie University Hospital, 2-174 Edo-
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